LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 38 filers reported holding LYRA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,044,000 | +13.6% | 1,100,852 | 0.0% | 71.28% | +403.3% |
| Q2 2021 | $8,840,000 | -30.7% | 1,100,852 | 0.0% | 14.16% | -14.4% |
| Q1 2021 | $12,759,000 | +1.7% | 1,100,852 | 0.0% | 16.54% | +1.0% |
| Q4 2020 | $12,550,000 | +2.0% | 1,100,852 | 0.0% | 16.38% | -19.3% |
| Q3 2020 | $12,308,000 | -1.4% | 1,100,852 | 0.0% | 20.29% | +108.9% |
| Q2 2020 | $12,484,000 | – | 1,100,852 | – | 9.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,777,251 | $3,572,275 | 0.74% |
| Perceptive Advisors | 9,146,730 | $18,384,927 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 1,996,972 | $4,013,914 | 0.41% |
| VR Adviser, LLC | 924,170 | $1,857,582 | 0.36% |
| Nantahala Capital Management | 2,220,830 | $4,463,868 | 0.34% |
| Ikarian Capital, LLC | 343,685 | $711,427 | 0.16% |
| Soleus Capital Management, L.P. | 592,417 | $1,190,758 | 0.12% |
| Clearline Capital LP | 119,128 | $239,448 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 146,800 | $303,876 | 0.01% |
| Tower Research Capital LLC (TRC) | 9,972 | $20 | 0.00% |